Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-26-157014
Filing Date
2026-04-15
Accepted
2026-04-15 16:10:42
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A d116643ddefa14a.htm DEFA14A 175830
2 GRAPHIC g116643g0414134417370.jpg GRAPHIC 1207
3 GRAPHIC g116643g0415223952067.jpg GRAPHIC 3544
  Complete submission text file 0001193125-26-157014.txt   184024
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37627 | Film No.: 26864260
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)